Contracts › 75N93021F00239
75N93021F00239: This Task Order Is to Develop an Optimized Phase 1 Cgmp Manufacturing Process for Lipid Nanoparticle (LNP) Fabrication That Enable Covalent Coupling of an Hiv-1 Env Trimer to the Surface of the Lnp. a Non-Gmp Process Run of Drug Product Shall Be Perf
Awarded to International Aids Vaccine Initiative Inc. by National Institutes of Health (NIH).
$2.3Mobligated
$2.3Mpotential value
31 August 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93021F00239 |
|---|---|
| Vehicle | HHSN272201600011I |
| Awardee | International Aids Vaccine Initiative Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 Research and Development in the Physical, Engineering, and Life Sciences (Except Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | NY |
| Period of performance | 15 September 2021 to 31 August 2028 |
| Potential end | 31 August 2028 |
| Estimated recompete solicitation | ~Q1 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541712 contracts · All expiring contracts · USASpending record